MRVI · Company research
Maravai LifeSciences Holdings, Inc. Class A Common Stock (MRVI): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 7.43 | $1,129,209,480 | 1059118480.00 | 4.4550898203592814 | — | — | 21.9511193188445239 | 3.1756118879152277 | 311.76407509663169524452 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.